Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
EPCAM (Epithelial cell adhesion molecule)
i
Other names:
EPCAM, 17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1, Epithelial cell adhesion molecule
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4072
Related tests:
‹
BRCANext®
BrainTumorNext®
COLARIS®
CancerNext ®
CancerNext-Expanded®
ColoNext®
ColoSeq™
CustomNext-Cancer®
Devyser LynchFAP
Empower™ Hereditary cancer test
GALEAS™ Hereditary Plus
GYNplus®
Invitae Common Hereditary Cancers Panel
Labcorp® Plasma Complete™
Myriad myRisk® Hereditary Cancer
NovoFocus™ PARPi CDx
OvaNext®
PancNext®
ProstateNext®
QVantageᵀᴹ
RenalNext™
Tempus xG+
Tempus xO assay
TheraMap Test
TumorNext-Lynch
BRCANext®
BrainTumorNext®
COLARIS®
CancerNext ®
CancerNext-Expanded®
ColoNext®
ColoSeq™
CustomNext-Cancer®
Devyser LynchFAP
Empower™ Hereditary cancer test
GALEAS™ Hereditary Plus
GYNplus®
Invitae Common Hereditary Cancers Panel
Labcorp® Plasma Complete™
Myriad myRisk® Hereditary Cancer
NovoFocus™ PARPi CDx
OvaNext®
PancNext®
ProstateNext®
QVantageᵀᴹ
RenalNext™
Tempus xG+
Tempus xO assay
TheraMap Test
TumorNext-Lynch
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
EPCAM positive + CD44 positive + CD24 negative
Breast Cancer
EPCAM positive + CD44 positive + CD24 negative
Breast Cancer
tamoxifen
Resistant: C3 – Early Trials
tamoxifen
Resistant
:
C3
tamoxifen
Resistant: C3 – Early Trials
tamoxifen
Resistant
:
C3
EPCAM positive + CD44 positive + CD24-L
Breast Cancer
EPCAM positive + CD44 positive + CD24-L
Breast Cancer
tamoxifen
Resistant: C3 – Early Trials
tamoxifen
Resistant
:
C3
tamoxifen
Resistant: C3 – Early Trials
tamoxifen
Resistant
:
C3
EPCAM expression
Triple Negative Breast Cancer
EPCAM expression
Triple Negative Breast Cancer
JQ-1
Resistant: C3 – Early Trials
JQ-1
Resistant
:
C3
JQ-1
Resistant: C3 – Early Trials
JQ-1
Resistant
:
C3
CD47 expression + EPCAM expression
Small Cell Lung Cancer
CD47 expression + EPCAM expression
Small Cell Lung Cancer
VBI-003
Sensitive: D – Preclinical
VBI-003
Sensitive
:
D
VBI-003
Sensitive: D – Preclinical
VBI-003
Sensitive
:
D
CD47 expression + EPCAM expression
Colorectal Cancer
CD47 expression + EPCAM expression
Colorectal Cancer
VBI-003
Sensitive: D – Preclinical
VBI-003
Sensitive
:
D
VBI-003
Sensitive: D – Preclinical
VBI-003
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.